I think there is an SP manipulation issue - you only have to see the number of very small trades that come in at below the SP at the time. No one looks at a company where the SP is trending upwards after an announcement and then sells a small parcel at a lower price and when that is happening several times in a trading session - and every trading session - something does not feel right. I am not into conspiracy theories - and I get the irony of me just pointing one out of my own - but it is hard to fathom out why this is happening.
Over the last two months, there have been some very material announcements - mixed in with some minor ones of course. It would be logical that the SP would be positively affected - and that has not happened. A company announces almost a $1mil total revenue increase from a previous quarter where revenue was almost non existent - that is not talking up a situation. That is a significant change in circumstances. That is the basis of a potential enhanced future. All that promise needs to be realised of course but it certainly should have had a visible SP nudge upwards.
12 months ago, MXC was a shambles. Today, you could almost be forgiven for thinking this is a different company altogether. Some decisions made in 2018 defy logic and do appear to be very amateurish as you pointed out. I am heartened that there seems to be a change in management style and, perhaps, a renewed energy in getting MXC back on track. The move to focus on MM may well be the catalyst for that change.
- Forums
- ASX - By Stock
- RGT
- Ann: Pharma Update - Increased Orders and Clinical Study
RGT
argent biopharma limited
Add to My Watchlist
15.4%
!
16.5¢

Ann: Pharma Update - Increased Orders and Clinical Study, page-31
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.5¢ |
Change
-0.030(15.4%) |
Mkt cap ! $9.483M |
Open | High | Low | Value | Volume |
19.5¢ | 19.5¢ | 16.0¢ | $12.93K | 71.86K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 12500 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.5¢ | 20950 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 12500 | 0.160 |
1 | 1500 | 0.155 |
2 | 24225 | 0.150 |
1 | 7400 | 0.135 |
2 | 10000 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.195 | 20950 | 1 |
0.200 | 15000 | 1 |
0.210 | 63 | 1 |
0.215 | 210 | 1 |
0.220 | 16080 | 2 |
Last trade - 14.04pm 04/04/2025 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |
The Watchlist
AUK
AUMAKE LIMITED.
CEO Hai Yun Chen, Non-Executive Chairman Anthony Noble
CEO Hai Yun Chen
Non-Executive Chairman Anthony Noble
SPONSORED BY The Market Online